New Tool: ProSource
Checkout our packaging and processing solutions finder, ProSource.

3D Printed Organs Are on the Horizon

There are 106,075 people in the United States awaiting organ transplants, but living donors only provide ~6,000 organs a year.

Shutterstock Lung 768x432
Nixx Photography/Shutterstock.com

When a patient needs an organ, there are two main hurdles in their way: finding a donor match, and ensuring their body doesn’t reject the new organ. According to a recent CNN Health article, 3D-printed organs could alleviate the pressure placed on donor lists by creating personalized organs from the patient’s own cells.

Organ bioprinting is a new type of regenerative medicine that is still in its development stage, but it could be commonplace in as little as ten years. It employs 3D-printing techniques to combine multiple types of cells, growth factors and biomaterials and assembles them layer-by-layer to create functional bioartificial organs. 

Doctors begin by extracting the patient’s cells via a minimally invasive autopsy. These cells are isolated and grown in a sterile incubator or bioreactor that mimics the internal temperature and oxygenation of the human body and feeds them nutrients. They are then mixed with a glue-like gel to create bioink, a printable mix of living cells, hydrogels and the media and growth factors that make cells proliferate and differentiate. They are then ready to print, a process that can take several hours. The time from biopsy to implantation is about 4-6 weeks.

Discover Our Content Hub
Access Packaging World's free educational content library!
Read More
Discover Our Content Hub
How AI is reshaping CPG manufacturing operations
Today’s CPG companies are faced with mounting challenges in their manufacturing operations. You have the data that could help you, but can you turn that data into knowledge? See how artificial intelligence can help. Learn what’s working for Pfizer, Post, and Smithfield.
Read More
How AI is reshaping CPG manufacturing operations